glp 1 drugs origin Discovery of GLP-1–Based for the Treatment of Obesity History of GLP-1 Medications -
Description
3. Marso SP , et al
As a result, several post hoc analyses have investigated the risk of developing pancreatitis as a result of DPP-4 inhibitor therapy
medication is not included
Multiple mechanisms likely contribute: Weight loss: Reduces cardiac workload, improves blood pressure, and improves lipid profiles
The study used electronic health records (EHRs) from the TriNetX US Collaborative Network, covering over 100 million patients
